Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Sep 28, 2011

Premium

Martin Madaus has been named Quanterix's permanent CEO. Madaus, who is chairman of the company, had been serving as interim CEO since May when David Okrongly left the Cambridge, Mass.-based company.

Madaus has served as a director of Quanterix since 2010, and became chairman of the firm last December. Prior to joining Quanterix, he served as president, chairman, and CEO of Millipore before it was acquired by Merck KGaA last year.


Former Solexa CEO John West has been named CEO of startup Personalis, a human genome analysis firm co-founded by West and Stanford University researchers Euan Ashley, Russ Altman, Atul Butte, and Mike Snyder.

Following Illumina's 2006 acquisition of Solexa, West served as senior vice president and general manager for Illumina's DNA sequencing business. Before joining Solexa as CEO in 2004, West was vice president of DNA platforms at Applied Biosystems.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.